Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Improving outcomes in diabetic nephropathy.

Trial Profile

Improving outcomes in diabetic nephropathy.

Phase of Trial: Phase II

Latest Information Update: 09 Mar 2010

At a glance

  • Drugs Losartan (Primary) ; Spironolactone (Primary) ; Lisinopril
  • Indications Diabetic nephropathies; Hypertension; Proteinuria
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 01 Dec 2009 Primary endpoint 'Urinary albumin:creatinine ratio' has been met.
    • 01 Dec 2009 Results published in the Journal of the American Society of Nephrology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top